OFIX Orthofix Accounting Capitalization

Corporate emblem and logo of orthofix.com (OFIX)

This current price chart allows for an assessment of the market capitalization of Orthofix Medical Inc. (OFIX), whose revenue is based on the supply of limb and spine correction systems to clinics. The integration of implants with tissue regeneration devices creates a closed-loop therapy cycle, cementing the company's status as a key counterparty for surgeons. Meanwhile, the 0.43 metric complements the picture of the struggle against corporate behemoths, where a bet on unique biomaterials helps maintain profitability.

Orthofix Medical (OFIX) - Company Book Value from 07/04/2022 to 10/27/2026
Mass-produced product of Orthofix International

Book value capitalization reflects the real value of net assets, determined by multiplying the number of shares by their book value. For Orthofix Medical Inc. (OFIX), the trend in the company's net book assets illustrates the effectiveness of the SeaSpine integration and the expansion of its implant portfolio. This metric allows investors to filter out market noise from actual capital growth. It is critical for investors to compare this basis with current quotes to identify overvaluation, as a significant gap signals the speculative nature of the current price.

Competitor analysis for Orthofix Medical Inc.

Boston Scientific Corporation Inc. (BSX) - Book Valuation of Business|Company Net Assets Edwards Lifesciences|RMD (resmed.com) - Accounting Capitalization|PODD: Company Book Value|Book Valuation of Business ZBH|COO - Company Book Value|Net Asset Value Align Corp (ALGN)|GMED: Book Capitalization|Total Stockholders' Equity TransMedics Organ Care System TMDX|ATEC: Book Capitalization|AORT - Company Net Assets|DJO Global - Book Capitalization|Integra LifeSciences Inc. (IART) - Book Valuation of Business|ESTA (Establishment Labs) - Book Capitalization|Book Capitalization BBNX|Company Book Value IRADIMED (IRMD)|Company Book Value Embecta Corp (EMBC)|Book Capitalization TNDM|AXGN - Book Valuation of Business|Company Net Assets SI-BONE, Inc.|BVS - Net Asset Value|Book Capitalization KIDS|Treace Medical Concepts Inc (TMCI) - Total Stockholders' Equity|Book Capitalization Strata Critical Medical Corp (SRTA)|Accounting Capitalization Carlsmed Medical (CARL)|RxSight, Inc. (RXST) - Company Net Assets|Accounting Value of Company CLPT (clearpointneuro.com)|Stereotaxis - Company Book Value|Company Net Assets Neuronetics Inc. STIM|SGHT (Sight Sciences, Inc) - Book Capitalization|OBIO - Total Stockholders' Equity|Book Capitalization anikatherapeutics.com|inspiremd.com (NSPR) - Accounting Capitalization|ZJYL: Book Capitalization|Book Valuation of Business Vivani|Book Capitalization XTNT (Xtant Medical Holdings)|Company Net Assets NeuroOne Medical Technologies Corp. (NMTC)|Book Capitalization MODD (Modular Medical, Inc.)|myomo.com - Book Capitalization|COCH - Company Book Value|Vivos Therapeutics Inc. (VVOS) - Company Book Value|Company Net Assets enVVeno NVNO|Sintx Technologies, Inc. (SINT) - Accounting Value of Company|Book Capitalization TNON (Tenon Medical, Inc.)|Total Stockholders' Equity LFWD|AMIX: Company Book Value|Book Value of Business INVO Bioscience IVF|Company Net Assets BBLG (Bone Biologics Corporation)|Book Capitalization Axonics, Inc AXNX|Book Capitalization BIOL (BIOLASE, Inc.)|DYNT: Book Valuation of Business|Company Book Value paragon28.com (FNA)|INVO (INVO Bioscience) - Net Asset Value